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ABSTRACT 
PURPOSE: To evaluate the effect of remote ischemic preconditioning (IPC-R) in the fetal small bowel transplantation model. 
METHODS: Two groups were constituted: The Isogenic transplant (ISO, C57BL/6 mice, n=24) and the allogenic transplant (ALO, 
BALB/c mice, n=24). In each group, the animals were distributed with and without IPC-R. It was obtained the following subgroups: Tx, 
IPC-R, Fk, IPC-Fk, in both strains. Intestinal grafts were stained with hematoxylin and eosin and immunohistochemically. 
RESULTS: The graft development evaluation in ISO group showed that IPC-R reduced the development compared with ISO-Tx 
(5.2±0.4 vs 9.0±0.8) and IPC-R-Fk increased the graft development compared with IPC-R (11.2±0.7 and 10.2±0.8). In ALO group, 
IPC-Fk increased the development compared with ALO-Tx and ALO with IPC-R (6.0±0.8, 9.0±1.2, 0.0±0.0, 0.5±0.3). The PCNA 
expression was increased in ISO group treated with Fk and IPC-R compared to other groups (12.2±0.8 vs Tx: 8.8±0.9, IPC-R: 8.0±0.4 
and Fk: 9.0±0.6). The graft rejection was lower in groups treated with IPC-R (-18%), Fk (-68%) or both (-61%) compared with ALO-Tx. 
CONCLUSION: Remote ischemic preconditioning showed benefic effect even associate with Tacrolimus on the development and 
acute rejection of the fetal small bowel graft in the Isogenic and Allogenic transplants.
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Introduction
Intestinal transplantation has become an accepted therapy 
for intestinal disease in patients who require total parenteral 
nutrition1. Although the results of small bowel transplantation 
have improved during the past few years, rejection, infection, 
preservation, and reperfusion injury continues to be a major 
obstacle. In transplantation surgery or complex trauma, the 
interruption and restoration of blood flow to organs and tissues, 
cause a cascade of events known as ischemia-reperfusion (IR) 
syndrome. The generation of free radicals during this event 
promotes cellular and membrane alterations causing cell death2. 
Some protection strategies have been used for 
the preservation amongst of the tissues, them the ischemic 
preconditioning (IPC). The IPC is a surgical alternative that 
employs short cycles of ischemia followed by reperfusion, 
previously to a sustained ischemia2. 
Murry et al.3, using the myocardium muscle of dogs, 
could register the protective effect of IPC through a number 
of experiments, when the term ischemic preconditioning was 
definitively divulged. In the small intestine dysfunction observed 
after sustained warm ischemia was prevented if preconditioning 
was carried out before the ischemia4.  The mechanism of remote 
preconditioning is not limited to one organ system either: Freitas 
et al.5 noted that maternal IPC protected the colonic mucosa of 
neonatal rats subjected to hypoxia and reoxygenation, reducing 
the morphological changes and the inflammatory response. In 
another study6, the authors showed that the IPC protected against 
ischemia-reperfusion injury in remote lung intestinal ischemia-
reperfusion on or hepatic model with acute diabetes. 
Considering that the IPC protects the gut in hypothermic 
condition improving post- transplantation7; the mechanism 
involves R-IPC different paths of action in relation to IPC, and 
that in a previous study in our lab, showed increased IPC-R cell 
proliferation and neovascularization of the ovarian graft8; it was 
decided to verify the role of intestinal transplantation IPC-R and 
its impact on intestinal development and in the process of acute 
allogeneic rejection.
Methods
All animals were handled according to the ethical 
principles of laboratory animal care (law 11.794, October 8, 2008), 
which governs the ethical use of animals for experimentation and 
followed the guidelines by the Research Ethics Committee of the 
UNIFESP (protocol n° 0864/08).
It was used four female C57BL/6 mice on the 18th day of 
pregnancy submitted or not to R-IPC, 24 BALB/c adult male mice 
and 24 C57BL/6 adult male mice. 
The females were weighed and then anesthetized using 
intramuscular (IM) injection of ketamine (80 mg/kg) and xylazine 
(10 mg/kg) and maintained on a heated pad (Gaymar T/Pump) 
at 37°C.  Using a clean technique, the IPC-R was accomplished 
by occlusion of the left femoral artery during 10 minutes, 
followed for similar time of reperfusion, following laparotomy, 
hysterotomy was accomplished, and a transverse laparotomy 
was performed in the fetus to expose the small intestine, using 
microsurgical x16 magnification. All intestines were harvested, 
cleaned from their mesentery, and divided into segments of 1-cm 
length. Nonvascularized small bowel grafts were immediately 
transplanted, in the space between the straight-abdominal muscle 
and pre-peritoneal of the recipients to half centimeter of the 
xiphoid appendix, left of the medium line. After the transplant, the 
abdominal wall was closed with prolene 7-0 sutures. 
The immunosuppressant used was Tacrolimus (Fk, 5 mg/
kg/day v.o.) and then, it was obtained the following subgroups: 
ALO-Tx, ALO-IPC, ALO-Fk, ALO-IPC-Fk, ISO-Tx, ISO-IPC, 
ISO-Fk and ISO-IPC-Fk.
 After seven days’ follow-up, the graft of small bowel 
was removed surgically and the animals were sacrificed by lethal 
dose of anesthetic compound.
Histomorphological evaluation
The sample was fixed in buffered formalin solution for 12 
hours and embedded in paraffin and stained by hematoxylin-eosin 
and periodic Acid-Schiff complemented with Alcian Blue staining 
(PAS / Alcian Blue).
For morphological analysis of the development process 
and/or graft rejection was used the score proposed by Auber et 
al. 9.
For morphometric study was performed under micro-
scope light coupled to a computerized imaging and program Im-
age J software. 
Immunohistochemical analysis
For immunohistochemistry, 4 uM slides sections treated 
with 3- aminopropyltriethoxysilane were used. The sections were 
deparaffinized in an oven at 60 °C for 12 hours, followed by xylol 
bath at room temperature for 30 minutes.
The slides were hydrated in ethanol baths with decreasing 
concentrations, washed in water and kept in phosphate buffered 
saline (PBS). Antigen retrieval was performed with Pascal pot use, 
cap 0.01 molar sodium citrate, pH 6.0, for 5 minutes, then cooling 
to room temperature for 20 minutes. Blockage of endogenous 
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peroxidase was performed with hydrogen peroxide solution (10 
vol), 5 min for 4 cycles followed by rinsing with tap water and 
distilled water.
For blocking nonspecific sites, sections were incubated 
in 1% solution of bovine serum albumin in PBS for 15 minutes, 
discarding the excess after this time. The primary antibody was 
diluted in PBS solution at a dilution of 1: 5000 for polyclonal 
anti-antigen mouse human proliferation (PCNA, Cell Signaling 
Technology), and incubated on the sections in a moist chamber 
for 18 hours at 4°C. Then, the sections were washed in PBS and 
incubated with biotinylated secondary antibody Advance kit 
(Dako) followed by incubation with streptavidin-biotin-peroxidase 
complex of the same kit. Incubations were performed in a moist 
chamber at room temperature for 15 minutes followed by rinses 
in PBS.
The development was performed with 1% solution of 
3,3’-diaminobenzidine (Sigma) and hydrogen peroxide in PBS 
for 5 min at room temperature, followed by washing in water. 
The counterstaining was performed with Harris hematoxylin for 
1 minute, followed by extensive washing in running water. After 
drying diafanization, the slides were mounted with Entellan resin 
(Sigma).
The analysis of immunohistochemistry was performed 
throughout fetal gut graft considering the villi crypt intestinal 
epithelium and muscle layer. Employed is a semi quantitative 
evaluation by scoring positively labeled cells second location 
criteria for the antibodies used.
Statistical analysis
The data were analyzed using the SigmaStat statistical 
program, version 3.1 (Systat Software, San Jose, CA). The analysis 
of variance (ANOVA and ANOVA on ranks), supplemented by test 
Student-Newman-Keuls or a Dunn, was used for the remainder of 
statistical analysis, which included the development score data, 
rejection and cell proliferation score. Difference was considered 
statistically significant when P < 0.05.
Results
In relation to assessment of the development of the 
fetal small bowel graft in isogenic transplantation after seven 
days of follow-up, the results showed that the development was 
significantly lower in the ISO-IPC group compared to the ISO-Tx 
group. The ISO-FK group and ISO IPC-FK group showed higher 
scores development of the graft as compared to ISO-IPC group 
(Figure 1).
FIGURE 1 - Development of the fetal small bowel graft in isogenic 
transplantation (ISO) after seven days of follow-up. ISO-Tx transplanted 
without treatment; IPC, transplanted submitted prior to remote ischemic 
preconditioning; Fk transplanted treated with Tacrolimus. *P <0.05 vs. 
ISO-Tx; #, P <0.05 vs ISO-IPC.
Already in allogeneic transplant group, the evaluation 
of the fetal small bowel graft showed that the development 
was significantly higher in the groups treated with tacrolimus 
when compared to ALO-Tx or ALO-IPC group. The IPC-R did 
not change significantly the development of graft in multiple 
comparison groups (Figure 2). However, the comparison between 
two independent groups, ALO-ALO and Fk-Fk-IPC, significance 
was observed (p = 0.035) to the beneficial effect of IPC-R in terms 
of development score.
FIGURE 2 - Development of the fetal small bowel graft in allogeneic 
transplantation (ALO) after seven days of follow-up. ALO-Tx, transplanted 
without treatment; IPC, transplanted submitted prior to remote ischemic 
preconditioning; Fk transplanted treated with Tacrolimus. *P <0.05 vs. 
ALO-Tx; #P <0.05 vs ALO IPC.
The evaluation of cellular proliferation in the isogenic 
transplantation group showed that the combination of the IPC-R 
and treatment with Tacrolimus promoted intense proliferation 
when compared to the other subgroups (12.2±0.8 vs Tx: 8.8±0.9, 
IPC-R,: 8.0±0.4 e Fk: 9.0±0.6) (Figure 3). The evaluation of the 
Morello RJ et al.
678 - Acta Cirúrgica Brasileira - Vol. 31 (10) 2016
cellular proliferation in allogeneic transplantation group showed 
no differences between subgroups. Similarly, there was not 
difference between cell proliferation when compared subgroups 
of allogeneic and isogenic transplants (p=0.28).
FIGURE 3 - Photomicrograph of the isogenic fetal small bowel graft 
after seven days of follow-up marked by immunohistochemistry with 
anti-PCNA antibody. In A, ISO-Tx group; B: ISO-IPC group; C: ISO-
Fk group; and D: ISO-Fk-IPC group. Can be observed numerous cryptic 
positively stained cells stained brown (x400).
The assessments of rejection of fetal intestine graft 
isogenic transplantation showed that there was no rejection. 
Already in the evaluation of rejection of fetal intestine graft in 
allogeneic transplantation, the results show that there was less 
rejection in grafts undergone the treatments. The IPC-R and Ta-
crolimus reduced rejection compared to ALO-Tx group. When 
associated therapeutic, no synergism or antagonism, which 
maintained the reduction of acute rejection (Figure 4).
FIGURE 4 - Rejection of fetal small bowel graft in allogeneic 
transplantation (ALO) after seven days of follow-up. ALO-Tx 
transplanted without treatment; IPC, transplanted submitted prior to 
IPC-R; FK transplanted treated with Tacrolimus. *P <0.05 vs. ALO-Tx; 
#P <0.05 vs ALO IPC.
Discussion 
This study showed that the IPC-R interferes with the 
development process and acute rejection of fetal small bowel 
graft. In the isogenic grafts, this strategy proved beneficial effect 
when added to tacrolimus treatment, in which there was the 
highest score development of the graft, as evidenced by increased 
cell proliferation. Similarly, in allogeneic grafts treated with 
Tacrolimus, IPC-R has promoted increased development and 
significant reduction in rejection.
The IPC has an important action in the attenuation of IR 
lesion and has the advantage of its possibility of use in the current 
surgical period, with no need of additional surgical procedures, and 
with no collateral effects from the use of drugs applied to raise the 
tissue viability. The association of this strategy with Tacrolimus 
demonstrated additional advantage, since this immunosuppressive 
drug is related to increased post-transplant survival10. 
The role of IPC in reducing ischemic injury has been 
widely documented in a range of tissues, including IR injury 
of the small intestine11–16. A recent study shows that Ischemic 
preconditioning increased the intestinal stem cell activities in the 
intestinal crypts in mice17.
In this study, the strategy of preconditioning used was 10 
minuts of ischemia and the same time for reperfusion. Similarly, 
Sola et al.7, using an experimental model in the study of intestinal 
transplantation in rats, achieved preconditioning with an ischemic 
interval of 10 minutes followed by reperfusion of 10 minutes. 
These results suggest that there is superiority of tissue protection 
when the IPC strategy in that way.
The graft development score described by Auber et al.9, 
it considers the presence of digestive epithelium, villi, crypts, 
muscular layer and importance of the mucous secretion. The 
damage observed in the development score promoted by R-IPC 
in isogenic grafts can be due to the cystic dilation of the graft, 
consequent of expressive mucus accumulation inside the of the 
intestinal light, due to the increase of globet cells, promoting 
larger amount of secretion committing the aspect of the villi in 
the mucous membrane, resulting in smaller score of development. 
Conditions of cystic dilation, as it happened in this group, refers to 
underestimated score. 
The contribution of this research was the beneficial effect 
of IPC-R on the transplanted intestine, both isogenic as allogeneic. 
These effects evidenced bowel transplantation model are novel and 
extremely important since it can make effective contributions to 
understanding the development of post-operative intestinal graft.
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Conclusions
 Remote ischemic preconditioning showed 
benefic effect even associate with Tacrolimus on the development 
and acute rejection of the fetal small bowel graft in the Isogenic 
and Allogenic transplants, increasing the cellular proliferation in 
isogenic trnasplants. In the Allogeneic transplant, it increased the 
development of the graft, it reduced the degree of acute rejection 
without Immunosuppression, however it didn’t present synergic 
effect with the immunosuppression. 
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